Host microbiota interactions regulate many aspects of immunity. Kim et al. demonstrate that microbial adhesion to intestinal epithelium helps regulate the balance between pro-and antiinflammatory T cell responses through induction of IL-10 by a subset of intestinal antigen-presenting cells.
SUMMARY
The intestinal barrier is vulnerable to damage by microbiota-induced inflammation that is normally restrained through mechanisms promoting homeostasis. Such disruptions contribute to autoimmune and inflammatory diseases including inflammatory bowel disease. We identified a regulatory loop whereby, in the presence of the normal microbiota, intestinal antigen-presenting cells (APCs) expressing the chemokine receptor CX 3 CR1 reduced expansion of intestinal microbe-specific T helper 1 (Th1) cells and promoted generation of regulatory T cells responsive to food antigens and the microbiota itself. We identified that disruption of the microbiota resulted in CX 3 CR1 + APCdependent inflammatory Th1 cell responses with increased pathology after pathogen infection. Colonization with microbes that can adhere to the epithelium was able to compensate for intestinal microbiota loss, indicating that although microbial interactions with the epithelium can be pathogenic, they can also activate homeostatic regulatory mechanisms. Our results identify a cellular mechanism by which the microbiota limits intestinal inflammation and promotes tissue homeostasis.
INTRODUCTION
The gastrointestinal tract is continuously exposed to a variety of potential immune stimuli including antigens from diet, commensal bacteria, and pathogens. This high antigenic load requires balance between inflammatory responses to harmful pathogens and tolerance to commensal microorganisms or food in order to maintain immune homeostasis and promote a healthy gut (Round and Mazmanian, 2009 ). Failure to regulate inflammatory T cells against environmental antigens is thought to drive the development of intestinal disorders including inflammatory bowel disease (IBD) (Sun et al., 2015; Wing and Sakaguchi, 2010) . Immune cells with the capacity to suppress excess inflammation are crucial to limit inflammatory diseases (Wing and Sakaguchi, 2010) .
T helper 1 (Th1) cell responses, while crucial for clearance of intracellular pathogens, are associated with autoimmune and inflammatory disorders (Cope et al., 2011) . Interferon-g (IFN-g), the prototypic Th1 cell effector cytokine, can induce tissue pathology associated with infectious disease (Dolowschiak et al., 2016) . IFN-g directly increases epithelial permeability both in vivo and in vitro (Beaurepaire et al., 2009) , resulting in increased food antigen, bacteria, and bacterial products entering the mucosa alongside elevated local immune responses (Balfour Sartor, 2007) . Therefore, IFN-g must be tightly regulated to mediate pathogen clearance while limiting unintended tissue damage.
A dynamic interaction between the host and microbiota shapes the development and responsiveness of both the mucosal and systemic immune systems (Round and Mazmanian, 2009; Sommer and B€ ackhed, 2013) . Studies in germ-free mice demonstrate reduced immune cellularity as well as a lack of organized structures such as B cell germinal centers, indicating an essential role for the microbiota (Round and Mazmanian, 2009; Sommer and B€ ackhed, 2013) . The microbiota also allows for proper induction of protective immunity against pathogens while also limiting aberrant responses against the microbiota and self-antigens. For example, production of interleukin-10 (IL-10), a critical immunoregulatory molecule, which downregulates IFN-g responses, requires the microbiota (Grainger et al., 2013) . Additionally, the microbiota is critical for induction of intestinal regulatory T (Treg) cells as they are absent in germ-free mice (Atarashi et al., 2011) . Disrupted signaling downstream of the microbiota, such as through loss of toll-like receptor pathways, is thought to drive disease pathology including in IBD (Zhou et al., 2016) . We and others have found that the microbiota is required for proper intestinal barrier repair through innate lymphoid cell production of IL-22 (Longman et al., 2014; Ouyang et al., 2011) . We also found that the microbiota serves to limit trafficking of antigen-presenting cells (APCs) from the intestinal lamina propria to the mesenteric lymph node (MLN), a site of T cell priming (Diehl et al., 2013) . As altered migration has the potential to regulate inflammatory T cell responses against intestinal antigens, we sought to understand the cellular signaling network between the microbiota and induction of T cell responses against intestinal antigens. Using antibiotics to disrupt the microbiota, we established that the presence of the intact microbiota led to reduction in Th1 cell responses against intestinal pathogens. This reduced response depended on chemokine receptor CX 3 CR1-expressing intestinal mononuclear phagocytes (MNPs) . In the presence of the intact microbiota, CX 3 CR1 + MNPs limited T effector cell expansion and promoted the differentiation of Treg cells against soluble antigens and the microbiota itself. In contrast, after microbiota disruption, CX 3 CR1 + MNPs promoted pathogen-specific Th1 cell expansion and contributed to tissue pathology. Antigen presentation and IL-10 production by CX 3 CR1 + MNPs were required to mediate these effects. We further defined a requirement for microbial adhesion to intestinal epithelial cells for induction of this regulatory loop. These data demonstrate a conditioning of CX 3 CR1 + MNPs by the intact microbiota that restrains pro-inflammatory Th1 cell responses and promotes anti-inflammatory Treg cell responses to sustain intestinal homeostasis.
RESULTS

The Microbiota Limits Th1 Cell Responses against Intestinal Pathogens
To understand how the microbiota impacts induction of intestinal immunity, we utilized infection with the intestinal pathogen Salmonella Typhimurium with or without prior antibiotic treatment to disrupt intestinal microbes. Antibiotics reduced fecal microbiota to the level of detection by qPCR ( Figure S1A ). We utilized antibiotic treatment because of immune defects, including loss of intestinal APCs, in germ-free animals (Bain et al., 2014; Round and Mazmanian, 2009 ). In our previous work, we have described an increased Salmonella-specific Th1 cell response in mice orally infected with a non-invasive mutant Salmonella after antibiotic disruption of the microbiota ( Figure S1B ; Diehl et al., 2013) . Non-invasive Salmonella is defective in the type III secretion system required for entry across epithelial barriers and requires host trafficking to enter tissues and reach the MLN (Diehl et al., 2013; Galá n, 2001; Vazquez-Torres et al., 1999 ). As we previously described, antibiotic depletion of the microbiota results in increased non-invasive Salmonella in the gut and MLN (Figures 1A and S1C ; Diehl et al., 2013) . Using non-invasive Salmonella, we therefore could not determine whether the differential immune response we observed was due to changes in tissue bacterial load or differences in local immunity. For this we needed an intestinal pathogen that demonstrates equivalent penetration into host tissues in the presence of the intact and disrupted microbiota. Invasive Salmonella is able to penetrate to the MLN (Vazquez-Torres et al., 1999) and we asked whether it reached equivalent bacterial numbers after antibiotic disruption of the microbiota. In contrast to infection with non-invasive Salmonella, infection with invasive Salmonella results in equivalent bacteria titers in the MLN in the presence of the intact or disrupted microbiota ( Figure 1A ). However, even in the presence of comparable antigen load, we found an increased Salmonella-specific Th1 cell response in intestine and MLN of mice with disrupted microbiota ( Figure 1B ). This indicates that increased bacterial penetration to the tissues was not driving the increased Th1 cell response. We previously demonstrated that infection with non-invasive Salmonella after antibiotic treatment allowed for increased MLN trafficking of CX 3 CR1 + MNPs ( Figure S1D ; Diehl et al., 2013) . After infection with invasive Salmonella, we observed increased CX 3 CR1 + MNPs in the MLN in animals with both normal and disrupted microbiota ( Figure 1C ). Therefore, we conclude that infection with invasive Salmonella would allow us to identify how microbiota signals impacted CX 3 CR1 + MNP function and the induction of intestinal inflammatory T cell responses. Thus, we utilized invasive Salmonella for the rest of our studies.
CX 3 CR1 + MNPs Drive Th1 Cell Expansion in Response to
Intestinal Pathogens after Microbiota Disruption To understand the role that CX 3 CR1 + MNPs play in the increased Salmonella-specific T cell response, we utilized mice in which CX 3 CR1 + MNPs or all CX 3 CR1 + cells could be selectively depleted after treatment with diphtheria toxin (DT) ( Figure S2A ; Diehl et al., 2013; Longman et al., 2014) . We administered DT to antibiotic-treated littermate Cx3cr1-STOP-DTR mice with (depletion of CX 3 CR1 + MNPs) or without (no depletion) Itgaxcre before infecting them orally with invasive or non-invasive Salmonella. After depletion of CX 3 CR1 + MNPs, we observed decreased non-invasive Salmonella titers in the MLN (Figure S2B ; Diehl et al., 2013) along with decreased Salmonellaspecific T cell responses ( Figure S2C ). In contrast, after infection with invasive Salmonella in antibiotic-treated mice, depletion of CX 3 CR1 + MNPs had no impact on MLN bacterial load ( Figure 2A ).
However, depletion of CX 3 CR1 + MNPs led to reduction in Salmonella-specific T cell responses ( Figure 2B ) and intestinal inflammation ( Figures 2C and 2D ). These findings led us to hypothesize that, after microbiota depletion, increased MLN CX 3 CR1 + MNPs were driving enhanced Th1 cell responses against invasive Salmonella. We performed similar experiments with Cx3cr1-DTR mice in which treatment with DT results in depletion of all CX 3 CR1 + cells including monocytes ( Figure S2A ). Similar to CX 3 CR1 + MNP-depleted mice, loss of all CX 3 CR1 + cells led to decreased Salmonella-specific T cell responses ( Figure S2D ).
We next wanted to understand whether CX 3 CR1 + MNPs drive Th1 cell expansion or differentiation of Salmonella-specific T cells after microbiota depletion. We orally infected antibiotic-treated mice with intact or depleted CX 3 CR1 + MNPs with Salmonella expressing a previously characterized 2W1S:I-A b CD4 + T cell epitope to allow for tracking of pathogen-specific T cells (Moon et al., 2007) . No expansion of 2W1S-specific T cells was observed in the absence of infection with 2W1S Salmonella or after CX 3 CR1 + MNP depletion (Figure S3A) . We analyzed the expansion and differentiation of MLN and intestinal 2W1S-specific T cells after 2W1S Salmonella infection by flow cytometry. We observed expansion of 2W1S-specific T cells in the MLN and intestine, the majority of which were T-bet + Th1 cells producing IFN-g ( Figures 2E and 2F ). 2W1S Th1 cell expansion was blunted after depletion of CX 3 CR1 + MNPs, but expanded cells still produced IFN-g albeit in reduced numbers ( Figures 2E and 2F ). We did not observe differential expansion or alterations in effector T cells that did not recognize the 2W1S antigen ( Figure S3B ). These data support a role for CX 3 CR1 + MNP-driven expansion of Salmonellaspecific Th1 cells after microbiota disruption.
To determine whether antigen presentation by CX 3 CR1 + MNPs was essential for this function, we bred Cx3cr1-creERT2 mice (Parkhurst et al., 2013) to mice with a conditional allele for MHCII I-A b (Hashimoto et al., 2002) . Treatment with 4-hydroxy tamoxifen (4OHT) resulted in loss of MHCII expression specifically in CX 3 CR1 + cells ( Figure S3C ). with Salmonella to assess induction of Salmonella-specific T cell responses. In contrast to our results with antibiotic treatment, mice depleted of CX 3 CR1 + MNPs with a normal microbiota had substantially increased T cell production of IFN-g in both the MLN and small intestine as compared to mice with normal numbers of CX 3 CR1 + MNPs ( Figure 3A ). We observed similar increased Th1 cell responses from mice in which all CX 3 CR1 + cells were depleted ( Figure S4A Figure S1 .
IFN-g by ELISA. As with mice infected with Salmonella, mice depleted of CX 3 CR1 + MNPs had increased Helicobacter-specific T cell production of IFN-g ( Figure 3B ). specific T cells in both the MLN and small intestine, the majority of which were T-bet + and produced IFN-g ( Figures  3C and 3D ), indicating that these cells limit expansion of Salmonella-specific T cells, thereby restraining the induction of Th1 cell responses against pathogenic intestinal microbes.
To determine whether antigen presentation by CX 3 CR1 + MNPs is required to limit T cell responses in the presence of the intact microbiota, we infected mice with normal expression of MHCII or lacking MHCII expression on CX 3 CR1 + MNPs with Salmonella and assayed for Salmonella-specific T cell responses. As with depletion of CX 3 CR1 + MNPs, in the presence of an intact microbiota, loss of antigen presentation by CX 3 CR1 + MNPs to CD4 + T cells led to enhanced Th1 cell response after Salmonella infection ( Figure S4B ). These data demonstrate a critical role for CX 3 CR1 + MNPs, in the presence of the intact microbiota, in limiting Th1 cell responses against intestinal microbes that are both pathogenic as well as potentially pathogenic such as pathosymbionts.
Responses against Soluble Oral Antigens One of the hallmark immune responses in the gastrointestinal tract is the induction of oral tolerance. Oral tolerance was described more than a hundred years ago as the ability of an orally administered antigen to inhibit subsequent priming of immune responses against that antigen (Pabst and Mowat, 2012 MNPs are required for induction of tolerance to fed proteins ( Figure 4A ). We did not observe defective oral tolerance in mice deficient in the chemokine receptor CX 3 CR1 ( Figure S4C ). To assess the direct impact of CX 3 CR1 + MNPs on the induction of antigen-specific Treg cells, we transferred OVA-specific OT-II T cells into mice with intact or depleted CX 3 CR1 + MNPs To understand the impact of the microbiota on induction of tolerogenic immune responses against soluble oral antigens, we evaluated oral tolerance as above but in animals with antibiotic-disrupted microbiota. In antibiotic-treated animals, we (legend continued on next page)
found that OVA feeding was insufficient to prevent the DTH response, indicating a reduced induction of tolerance to fed antigens ( Figure 4D ). This is supported by other findings in the literature that tolerance to oral antigens is defective in animals lacking microbiota-derived signals (Belkaid and Hand, 2014) . To understand whether there was altered differentiation of OVA-specific T cells after microbiota depletion, we transferred OT-II T cells into antibiotic-treated OVA-fed mice which were intact or depleted of CX 3 CR1 + MNPs. In animals with an intact microbiota, the vast majority of transferred T cells expressed FoxP3 in the absence of other T cell lineage-specific transcription factors ( Figures S4H and S4I (Saleh and Elson, 2011) . RAG2 À/À mice in our colony exhibit minimal disease after transfer of naive CD4 + T cells . This limited pathology is likely due to a lack of colonization with Helicobacter or other potentially proinflammatory members of the microbiota (Cahill et al., 1997; Coombes et al., 2005 Figure 5D ). Increased Th1 cells and decreased Treg cells were also observed in the MLN (Figure S5C ). To confirm sufficiency of monocytes or monocytederived cells, we transferred wild-type bone marrow monocytes along with naive T cells into RAG2 À/À CX 3 CR1 + cell-depleted mice. Previous work demonstrated that bone marrow monocyte transfer is sufficient to repopulate intestinal CX 3 CR1 + MNPs (Zigmond et al., 2012) . Monocyte transfer rescued weight loss and colitis score ( Figures S5D and S5E ) as well as reduced expansion of colonic Th1 cells and restored colonic Treg cells ( Figure S5F ).
In the T cell transfer model of colitis, transfer of Treg cells can protect from or ameliorate disease (Coombes et al., 2005 In the intestine, CX 3 CR1 + MNPs are the major producers of the anti-inflammatory cytokine IL-10 (Denning et al., 2007; Murai et al., 2009) . To determine whether the microbiota influenced IL-10 production, we isolated APCs from the intestine of untreated or antibiotic-treated animals and assessed IL-10 expression by qPCR and by flow cytometry of an Il10 GFP reporter . As compared to other APC populations, CX 3 CR1 + MNPs from animals with an intact microbiota had high expression of IL-10 transcript and a high proportion were positive for Il10-GFP, and expression was reduced in CX 3 CR1 + MNPs from animals treated with antibiotics ( Figures 6A, 6B , and S6A). We did not observe altered expression of other cytokines by CX 3 CR1 + MNPs after antibiotic treatment ( Figure S6B ).
To test the in vivo role for CX 3 CR1 + MNP-produced IL-10 and determine whether IL-10 production by CX 3 CR1 + cells was driving our observed effects, we bred Cx3cr1-creERT2 mice to mice harboring a conditional allele for IL-10 ( Roers et al., 2004 Figure S6C ) before infecting with Salmonella. Loss of IL-10 did not alter the proportion of CX 3 CR1 + MNPs in intestinal tissue (Figure S6D ). In animals with antibiotic-disrupted microbiota, loss of IL-10 production by CX 3 CR1 + MNPs did not impact induction of a Salmonella-specific T cell response ( Figure 6C ). In contrast, loss of IL-10 production by CX 3 CR1 + MNPs in the presence of an intact microbiota led to an increased Salmonella-specific T cell response in the MLN and small intestine, mirroring what we found when we depleted CX 3 CR1 + MNPs ( Figure 6C ). To track expansion of Salmonella-specific T cells, we infected untreated or antibiotic-treated animals with normal IL-10 or lacking IL-10 expression in CX 3 CR1
+ cells with 2W1S-expressing Salmonella. Loss of IL-10 production by CX 3 CR1 + cells led to increased number of Salmonella-specific IFN-g-producing T cells in the presence of the intact microbiota, but no alteration in Salmonella-specific Th1 cells after microbiota depletion ( Figure 6D ). We did not observe alteration in T cell responses not specific for Salmonella in this system (not shown). We also do not find that CX 3 CR1 + MNPs production of IL-10 regulates the function of CX 3 CR1 + MNPs themselves. Mice lacking IL-10 receptor on CX 3 CR1 + MNPs (IL-10 receptor flox mice [Pils et al., 2010] crossed to Cx3cr1-creERT2) showed no alteration in Salmonella-specific Th1 cell responses ( Figure S6E ).
To Figure 7A ; Dobrovolskaia and Vogel, 2002) . However, treatment of antibiotic-treated mice with LPS or colonization with the K-12 lab-adapted strain of E. coli did not induce in vivo IL-10 expression ( Figure 7B ). We previously identified that an adherent invasive E. coli (AIEC) strain 2A, isolated from a patient with Crohn's disease, induced intestinal inflammation in germfree mice deficient for IL-10 but not in wild-type germ-free mice (Viladomiu et al., 2017) . Using this isolate, as well as an additional Crohn's disease AIEC strain (541-15) (Baumgart et al., 2007) , we found that colonization with AIEC was sufficient to induce intestinal IL-10 expression in antibiotic-treated mice which was lost in the absence of CX 3 CR1 + MNPs ( Figure 7B ). AIEC drove IL-10 expression specifically in CX 3 CR1 + MNPs as shown by IL-10 reporter mice ( Figure 7C) . A virulence factor, shared by pathogens such as AIEC and Salmonella, is the long polar fimbriae (LPF) which is used to mediate epithelial adhesion in vivo and in vitro (B€ aumler et al., 1996; Dogan et al., 2014) . lpfA mutant AIEC 541-15 was unable to induce intestinal IL-10 expression although they had similar colonization ( Figures 7B and 7C and not shown). Colonization with AIEC 2A or 541-15 further protected antibiotic-treated mice from Salmonella-mediated intestinal pathology whereas E. coli K-12 or lpfA mutant 541-15 did not ( Figure 7D ( Figures 7G and S7C ). These data demonstrate that intestinal microbial adherence offers crucial signals to limit tissue inflammation and pathology through activation of anti-inflammatory signals in CX 3 CR1 + MNPs.
DISCUSSION
As regulating inflammation against intestinal microbes and dietary antigens is required for intestinal health, understanding how homeostasis is maintained remains a crucial question in the field of mucosal immunology. Using antibiotics to disrupt the microbiota, we identified intestinal microbes as key to limiting intestinal inflammation through their impact on CX 3 CR1 + MNPs. In previous studies, we have demonstrated that CX 3 CR1 + MNPs promote barrier repair and the microbiota regulates their trafficking to the MLN (Longman et al., 2014; Diehl et al., 2013 (Dolowschiak et al., 2016) . Collectively, the anti-inflammatory role of CX 3 CR1 + MNPs depends on the microbiota. Along with clearance of intestinal pathogens, the intestinal immune system must be tolerant to soluble food antigens. We were unable to induce oral tolerance in the absence of CX 3 CR1 + MNPs. Using transfer of antigen-specific T cells, we observed corresponding decreases in antigen-specific Treg cell induction. As with Th1 cell responses against pathogens, antigen presentation by CX 3 CR1 + MNPs is required for proper Treg cell expansion in response to soluble oral antigen. Further, similar to T cell responses against microbes, CX 3 CR1 + MNPs also limit the expansion of T cells specific for soluble intestinal antigens as we observed enhanced expansion of soluble antigen-specific T cells in the absence of CX 3 CR1 + MNPs. In contrast to previous reports (Hadis et al., 2011) , we did not observe a defect in oral tolerance in mice deficient in the chemokine receptor, CX 3 CR1, only in mice lacking CX 3 CR1 + MNPs. As we observed CX 3 CR1 + MNPs function was dependent on the microbiota and individual animal facilities have differences in mouse microbiota composition, this could indicate differential dependence on the chemokine receptor CX 3 CR1 in the presence of different microbes.
Moreover, we were unable to induce oral tolerance after antibiotic disruption of the microbiota. After OVA feeding of antibiotic-treated animals, instead of observing induction of primarily OVA-specific FoxP3 single-positive Treg cells, we found induction of inflammatory OVA-specific RORgt + Th17 cells. We also observed induction of RORgt and FoxP3 double-positive cells. A role for these cells in systemic tolerance to oral antigens is not defined. Within the colon, RORgt + FoxP3 + T cells represent a stable, microbiota-specific Treg cell population (Sefik et al., 2015; Yang et al., 2016) . In contrast, in human blood Th17 memory cells express both RORgt and FoxP3 and produce IL-17 upon restimulation (Voo et al., 2009) . These data indicate that they might have differential function in the intestine and other body sites. We conclude that disruption of the microbiota corresponds to pro-inflammatory T cell differentiation in response to food antigens together with failure to induce oral tolerance. IL-10 limits intestinal pathology (Moore et al., 2001 ) and we found CX 3 CR1 + MNPs to be a major producer of intestinal IL-10 with production strongly regulated by the microbiota. Microbiota-mediated IL-10 production by CX 3 CR1 + MNPs limited Th1 cell expansion against Salmonella and also drove Treg cell differentiation against soluble oral antigens. Previous work has found that IL-10R on CX 3 CR1 + MNPs limits induction of colitis (Zigmond et al., 2014) . We did not observe an impact of IL-10 autocrine signaling in CX 3 CR1 + MNPs in regulation of a pathogenspecific Th1 cell response. In the previous work, IL-10R was lost constitutively, but in our system, IL-10 or IL-10 receptor is lost, acutely revealing that IL-10 production by CX 3 CR1 + MNPs limits the induction of antigen-specific Th1 cell responses.
As there is increasing evidence that IBD results from a dysregulated interaction between the host immune system and its resident microbiota (Round and Mazmanian, 2009; Sommer and B€ ackhed, 2013) , our data support the hypothesis that the intestinal microbiota provides crucial signals to CX 3 CR1 + MNPs restraining the induction of inflammatory T cells and promoting induction of Treg cells. Understanding the microbial signals that regulate these anti-inflammatory signals is crucial to reestablish homeostasis in the context of inflammatory disease. Critical questions remain as to which microbiota signals drive the anti-inflammatory functions of CX 3 CR1 + MNPs. While microbial signals such as LPS or E. coli K-12 are sufficient to induce IL-10 production in vitro (Dobrovolskaia and Vogel, 2002) , we found that they were not sufficient to induce IL-10 or limit Th1 cell responses in vivo. In contrast, the capacity of intestinal microbes to adhere to the epithelium was critical for IL-10 induction and to limit Th1 cell responses against an intestinal pathogen. Intestinal microbe AIEC 2A is capable of inducing both Th17 cell responses and IL-10 expression and can induce pathology in the absence of IL-10 (Viladomiu et al., 2017) . This demonstrates that microbial pathways that are thought to be markers of pathogenicity or drivers of pro-inflammatory responses can also activate cellular networks to reduce tissue inflammation. Thus, they can be pathogenic in the context of host genetic alterations such as impaired anti-inflammatory signals. The outcome of such interactions between intestinal microbes and host is likely further dictated by the specific nature of the microbe and association with other markers of pathogenicity. As an additional example, adhesion of E. coli O157 to intestinal epithelial cells is required for induction of pro-inflammatory Th17 cell responses (Atarashi et al., 2015) . Along with our finding, this suggests that microbial adhesion to epithelium is a critical requirement for both pro-and anti-inflammatory host immune cell responses. For pathogenic organisms, inducing this regulatory pathway could support their ability to colonize the host by limiting immune clearance. Of direct relevance to IBD, a number of groups have identified increased colonization by AIEC in patients as compared to controls (Baumgart et al., 2007; Gevers et al., 2014; Viladomiu et al., 2017) . Our findings highlight the importance of integration of microbiota signals to balance between pro-and anti-inflammatory responses to intestinal antigens and pathogens. Epidemiological studies suggest that increased antibiotic exposure is associated with an increased risk for developing inflammatory diseases including IBD, celiac disease, and allergy (Belkaid and Hand, 2014) and our data suggest that this increased pathology could be due to a loss of microbiota-driven anti-inflammatory function in CX 3 CR1 + MNPs. By combining analysis of both pro-and anti-inflammatory responses, our studies demonstrate a critical role for the microbiota and their capacity to interact with the intestinal epithelium in regulating the inflammatory potential of a potent intestinal antigen-presenting cell, CX 3 CR1 + MNPs. Our work also demonstrates the potential therapeutic benefits of microbiota manipulation with the goal of amplifying or inhibiting intestinal T cell responses.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
DECLARATION OF INTERESTS STAR+METHODS
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experimental Animals CX 3 CR1-STOP-DTR, CX 3 CR1-DTR and CX 3 CR1-CreERT2 were previously described (Diehl et al., 2013; Longman et al., 2014; Parkhurst et al., 2013) . , and C57BL/6 mice (JAX # 000664). IL-10 and IL-10 receptor conditional mice were from Dr. Werner Muller (Pils et al., 2010; Roers et al., 2004) . All mice were kept in specific pathogen-free conditions and bred at the animal facility of the Skirball Institute or Baylor College of Medicine. Mouse experiments were performed with at least 3 mice per group and all mice were bred to generate littermate control animals for each experiment. Littermates were randomly assigned to experimental groups. Animals were used between 6 -12 weeks of age with males and females used in approximately equal ratios. All animal experiments were performed in accordance with approved protocols for the NYU or BCM Institutional Animal Care and Usage Committee.
Diphtheria toxin (DT) and 4-hydroxy tamoxifen (4OHT) administration Mice were intraperitoneally (I.P.) injected every other day with 200ng diphtheria toxin (DT, Sigma) in saline. (Z)-4-Hydroxytamoxifen, 98% Z isomer (4OHT, Sigma) was resuspended to 20mg/ml in ETOH with heating to 37 C. 4OHT was diluted to in corn oil (Sigma) and mice were injected every 3 days with 0.2mg by I.P.
Depletion of gut commensal microbiota
Animals were administered a single dose of 20 mg streptomycin (Sigma) per os (P.O.) and provided ampicillin (Sigma) at 1 g/L in drinking water for 1-2 weeks. Mice were switched to water without antibiotics two days before infecting or treating them as below. Bacterial DNA in feces was determined by qPCR after antibiotic treatment.
Infection with S. Typhimurium
For assessing T cell responses and tissue inflammation, mice were infected orally with 3X10
8 Salmonella DAroA colony forming unit (cfu) or 3X10 8 DAroA/DinvA cfu in 100 mL of phosphate-buffered saline (PBS). For bacterial titers animals were infected with 3X10 8 Salmonella cfu or 3X10 8 DinvA cfu in 100 mL of PBS. For titers, organs were homogenized two days after infection, diluted in PBS and plated on LB agar with streptomycin (50 mg/ml). Colony counts were expressed as cfu per organ. 2W1S-expressing DAroA Salmonella was a kind gift of Dr. M. Jenkins, University of Minnesota, Minneapolis, MN. For T cell analysis and histological analyses, mice were analyzed 10-12 days after infection.
Colonization of mice with E. coli Before colonization, mice were treated with antibiotics as above. E. coli were cultured overnight in LB media with or without selective antibiotics. Antibiotic treated mice were colonized with E. coli isolate: lab adapted E. coli strain K-12 or human AIEC strains (2A and 541-15) and 541-15 mutant strain (541-15DlpfA) at 1X10 9 cfu p.o.. Colonization was confirmed by qRT-PCR with E. coli specific primers. For LPS treatment, antibiotic treated mice were injected every other day with 0.3 mg LPS (Sigma).
OVA specific Immune responses
For transfer of OVA-specific OTII cells, T cells were isolated from the lymph nodes of Ly5.1 + OTII-Tg + mice. 2X10 6 cells were injected I.V. into Ly5.2 recipient animals. Animals were given 1.5% OVA in their drinking water (changed every other day) and T cell responses were measured 12 days after transfer. Oral tolerance studies were performed as described in (Hadis et al., 2011) . Mice were tolerized with 25mg of ovalbumin (OVA, Type V, Sigma) P.O. every other day. 7d later, mice were immunized subcutaneously with 250ug OVA in a PBS and CFA emulsion. 7d later mice were challenged with injection of 50ug OVA in the footpad. PBS was injected into the opposite side for control purposes. Footpad thickness was measured in a blinded fashion prior to injection and 48 hr after injection. OVA-specific footpad swelling was calculated as the relative swelling as compared to t0 of the OVA injected footpad versus the PBS injected footpad. To determine the microbiota impact, mice were treated with antibiotics 1 month before and throughout oral tolerance experiment.
Adoptive transfer colitis
Induction of colitis by transfer of naive T cells into a lymphopenic recipient was performed as described (Coombes et al., 2005 
METHOD DETAILS
Ex vivo measurement of Salmonella-specific T cell responses For antigen specific T cell responses, single-cell suspensions from the indicated organ were first negatively depleted with anti-B220 and anti-CD8 magnetic microbeads (Miltenyi Biotec). The depleted fraction was stained and cell sorting was performed on an Aria flow cytometer (BD Biosciences) to obtain memory and/or effector TCRb + CD4 + CD44 + CD62L À T cells (> 99% purity). These cells were plated at 1 3 10 5 cells per well with 5 3 10 5 irradiated splenocytes and 1 mg of heat-killed Salmonella. At 24 h, IFN-g in the supernatant was measured by ELISA (BD Biosciences).
Cell isolation
Small or large intestinal lamina propria cells were isolated as previously described (Diehl et al., 2013) . Briefly, mouse intestines were washed in PBS, once with 1 mM DTT and twice with 30 mM EDTA, and then digested in collagenase 8 (Sigma-Aldrich) and DNase-containing media with 10% fetal bovine serum. Digested material was passed through a cell strainer and separated on a discontinuous 40%/80% Percoll gradient. MLN cells were isolated by mechanical grinding using frosted glass slides.
Antibodies, cell staining, and flow cytometry Flow cytometric analysis was performed on a LSR II (BD Biosciences) and analyzed using FlowJo software (Tree Star Inc.). Cell sorting was performed on an Aria Cell Sorter (BD Biosciences). Antibodies were from BD PharMingen, eBiosciences or BioLegend. DAPI or UV live/dead fixable dead cell stain (ThermoFisher) was used to exclude dead cells. All samples were stained with CD16/32 (Fc receptor) to prevent non-specific antibody binding. Total cell counts were determined with123count eBeads (ThermoFisher). For intracellular staining of IFN-g and IL-17A cells were activated in RPMI 1640 (10% fetal bovine serum) with phorbol myristate acetate (50 ng/ml), ionomycin (1 mM), and GolgiPlug (BD bioscience) for 4 h. Cells were then stained for surface antigens (CD3, TCRb, and/or CD4). Cells were then fixed, permeabilized, and stained with antibodies to IL-17A, or IFN-g. Cells were stained with an antibody to mouse FoxP3, T-bet, GATA-3, or RORgt according to the manufacturer's protocol (eBioscience). For antigen presenting cells staining, cells were stained with antibodies for CD11b, CD11c, MHCII, CD103, and CX 3 CR1. For bone marrow monocyte staining, cells were stained with antibodies for CD11b, Ly6C, Ly6G, and CX 3 CR1. For 2W1S tetramer staining, cells were stained with tetramer on ice for 1hr before staining with antibodies as above. Tetramer was a kind gift of Dr. M. Jenkins, University of Minnesota, Minneapolis, MN and from the NIH tetramer core.
RNA extraction and real-time RT-PCR RNA from FACS sorted primary intestinal CX 3 CR1 + MNPs or total lamina propria cells was prepared with Trizol (Invitrogen). RNA was reverse transcribed into cDNA (SuperScript III; Invitrogen) and qPCR was performed with a Lightcycler with SYBR Green Supermix (Roche), 20 pmol forward and reverse primers, and 0.1 mg of cDNA. The thermocycling program was 40 cycles at 95 C for 15 s, 60 C for 30 s, and 72 C for 30 s, with an initial cycle of 95 C for 2 min. Relative expression of target gene were determined by using the delta Ct value compared to delta Ct (GAPDH) using the following primer sets: mIL-10-F: CATCATGTATGCTTCTATGCAG; mIL-10-R: CCAGCTGGACAACATACTGCT, GAPDH-F: ACCACAGTCCATGCCATCAC; GAPDH-R: TCCACCACCCTGTTGCTGT, IL-6-F: CCA GAGATACAAAGAAATGATGG; IL-6-R: ACTCCAGAAGACCAGAGGAAAT, IL-12p35-F: AGACGGCCAGAGAAATGAA; IL-12p35-R: GTTTGGTCCCGTGTGATGTCTT, IL-12p40-F: TGTGGGAGAAGCAGACCCTTA; IL-12p40-R: GGGTGCTGAAGGCGTGAA, IL23p19-F: CCAGCAGCTCTCTCGGAATC; IL-23p19-R: GATTCATATGTCCCGCTGGTG.
In vitro RAW cell culture RAW 264.7 macrophage cells (ATCC) were plated in DMEM media containing 10% FBS at 5X10 5 cells per 24 well. Cells were treated with 5X10 6 of indicated E. coli. Plates and spun down for 10 min at 1,000 g followed by a 1 hr incubation at 37 C. Cells were washed with sterile PBS and media was replaced with new media containing 100ug/ml gentamycin. Media was replaced one hour later with media containing 20ug/ml gentamycin. For LPS treatment, 1 mg/ml LPS was added. 24hr later, supernatants were harvested and IL-10 was assessed by ELISA (BioLegend).
Histopathology
Tissues were fixed in 10% neutral buffered formalin, routinely processed, sectioned at 6 mm, and stained with hematoxylin and eosin (H&E) for light microscopic examination. Samples were assessed in a blinded fashion by a trained pathologist. Samples were scored 0 to 4 based on the criteria described in (Berg et al., 1996) : (grade 0) no change from normal tissue; (grade 1) One or a few multifocal mononuclear cell infiltrates in lamina propria with minimal epithelial hyperplasia and slight to no depletion of mucus from goblet cells; (grade 2) More tissue involved or more frequent lesions than grade 1 including increased neutrophils along with mild epithelial hyperplasia and mucin depletion and occasional or small epithelial erosions with rare submucosal involvement; (grade 3) large area of mucosa involvement or more frequent lesions than grade 2 with moderate inflammation and submucosal involvement along with rare transmural and/or crypt abscesses and moderate epithelial hyperplasia, mucin depletion and ulcers; (grade 4) Involvement of most of the intestinal section and more severe than grade 3 including transmural lesions, marked epithelial hyperplasia, marked mucin depletion along with abscesses and ulcers.
QUANTIFICATION AND STATISTICAL ANALYSIS
One-way analysis of variance (ANOVA) with Bonferroni's posttest, Mann-Whitney U-test (2-tails), or unpaired t test was performed using a 95% confidence interval. Weight loss was compared using linear regression. All analyses were performed using GraphPad Prism version 5.0. Differences were considered to be significant at P values of < 0.05. Statistical significance is indicated as follows: ns: p > 0.05, *: p % 0.05, **: p % 0.01, ***: p % 0.001
